Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The MEDOS/HIA system: development, results, perspectives.

H Reul1

  • 1Helmholtz-Institut of Biomedical Technology, Rheinisch-Westfälische Technische Hochschule, Aachen, Germany.

The Thoracic and Cardiovascular Surgeon
|April 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The MiniACcor: constructive redesign of an implantable total artificial heart, initial laboratory testing and further steps.

The International journal of artificial organs·2007
Same author

New fiber configuration for intravenous gas exchange.

The International journal of artificial organs·2005
Same author

Design and in vitro performance of a novel bileaflet mechanical heart valve prosthesis.

The International journal of artificial organs·2005
Same author

Collected nondimensional performance of rotary dynamic blood pumps.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2004
Same author

Investigation of materials for blood-immersed bearings in a microaxial blood pump.

Artificial organs·2003
Same author

[First experiences with a miniaturized heart-lung-machine].

Biomedizinische Technik. Biomedical engineering·2002
Same journal

Comment: Topical Use of Tranexamic Acid in Cardiac Surgery: A Meta-Analysis.

The Thoracic and cardiovascular surgeon·2026
Same journal

Long-Term Redo CABG Outcomes: Propensity-Matched On-Pump vs Off-Pump Comparison.

The Thoracic and cardiovascular surgeon·2026
Same journal

PULMONARY ENDARTERECTOMY IN PEDIATRIC PATIENTS: INSTITUTIONAL EXPERIENCE.

The Thoracic and cardiovascular surgeon·2026
Same journal

Surgical Repair of Acquired Ventricular Septal Defects: Outcomes and Quality of Life.

The Thoracic and cardiovascular surgeon·2026
Same journal

The Use of Intra-Aortic Balloon Pumping in Cardiac Surgery.

The Thoracic and cardiovascular surgeon·2026
Same journal

Conflicts of Interest-From "Jein" to Transparency.

The Thoracic and cardiovascular surgeon·2026
See all related articles

The MEDOS/HIA Cardiac Support Device, featuring an improved blood pump valve and production technique, has been successfully used in 217 patients since 1994, demonstrating effective cardiac assistance.

Area of Science:

  • Cardiovascular Engineering
  • Biomedical Devices
  • Clinical Translation

Background:

  • The development of cardiac-assist devices is crucial for managing end-stage heart failure.
  • Previous cardiac support devices faced challenges with hemocompatibility and device performance.
  • The MEDOS/HIA device aimed to address these limitations through innovative design and production.

Purpose of the Study:

  • To detail the clinical development and outcomes of the MEDOS/HIA Cardiac Support Device.
  • To highlight key design improvements, including a novel three-leaflet blood pump valve.
  • To report on the device's effectiveness, safety, and clinical adoption.

Main Methods:

  • Development influenced by animal experiment results.
  • Novel construction of a three-leaflet blood pump valve for improved dynamic blood flow.

Related Experiment Videos

  • Modified production techniques to reduce thrombotic complications and enhance handling.
  • Testing of multiple pump sizes in animal experiments.
  • Clinical introduction and patient data collection.

    • Main Results:

    • Substantial improvement in the dynamic blood flow of the pump.
    • Reduction in thrombotic complications and improved device handling.
    • Successful clinical introduction of the MEDOS/HIA Cardiac Support Device in February 1994.
    • Use in 217 patients by the end of 1997.
    • Availability in different sizes for broader patient access.

    Conclusions:

    • The MEDOS/HIA Cardiac Support Device represents a significant advancement in cardiac-assist technology.
    • The improved valve design and production techniques contribute to enhanced patient outcomes.
    • The device has demonstrated successful clinical application and adoption since its introduction.